Document is current
Any future updates will be listed below
-
Authors
Karslı, Berkhan https://orcid.org/0000-0003-0763-1078
Meisinger, Verena
Hasanaj, Genc https://orcid.org/0000-0001-9807-1015
Kallweit, Marcel S.
Dengl, Fanny
Vural, Gizem https://orcid.org/0000-0003-0501-1879
Melcher, Julian
Korman, Maxim https://orcid.org/0009-0002-7489-8442
Klimas, Nicole
Schmölz, Susanne
Šušnjar, Antonia
Hisch, Alexandra
Krčmář, Lenka
,
Boudriot, Emanuel https://orcid.org/0000-0001-6083-6318
Moussiopoulou, Joanna https://orcid.org/0000-0002-0157-6197
Yakimov, Vladislav https://orcid.org/0000-0001-9559-7492
Pogarell, Oliver https://orcid.org/0000-0001-6455-4190
Schmitt, Andrea https://orcid.org/0000-0002-5426-4023
Falkai, Peter https://orcid.org/0000-0003-2873-8667
Geyer, Thomas
Roell, Lukas https://orcid.org/0000-0002-0284-2290
Wagner, Elias https://orcid.org/0000-0002-7147-6167
Raabe, Florian J. https://orcid.org/0000-0001-8538-0783
Keeser, Daniel https://orcid.org/0000-0002-0244-1024
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 11 January 2026
First Online: 23 January 2026
Competing interests
: The authors declare that they have no biomedical financial interests or potential conflicts of interest regarding the content of this report. P.F. received paid speakership by Boehringer-Ingelheim, Janssen, Otsuka, Lundbeck, Recordati, and Richter and was member of advisory boards of these companies. E.W. was invited to advisory boards from Recordati, Teva and Boehringer Ingelheim. Apart from P.F. and E.W., no other member of the CDP Working Group has a conflict of interest to report.
: During the preparation of this work the authors used the GPT – 4 model developed by OpenAI to improve readability and language of the manuscript. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.
